Browsing by Yonsei Author : Ahn, Sang Hoon

eperson profile image
Name:
Ahn, Sang Hoon [안상훈]
orcid http://orcid.org/0000-0002-3629-4624
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Scopus ID :
Scopus (7401989551)

Keyword Cloud

Researcher Network

Showing results 1 to 50 of 471

This table browses all dspace content
Issue DateTitleJournal Title
2021Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinomaJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2021Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease CANCERS
2021Pathological predictive factors for late recurrence of hepatocellular carcinoma in chronic liver diseaseLIVER INTERNATIONAL
2021Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort StudyDIGESTIVE DISEASES AND SCIENCES
2021Dynamics of liver stiffness-based risk prediction model during antiviral therapy in patients with chronic hepatitis BEUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
2021Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetesJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2021External validation of CAGE-B and SAGE-B scores for Asian chronic hepatitis B patients with well-controlled viremia by antiviralsJOURNAL OF VIRAL HEPATITIS
2021Hepatitis B Core-Related Antigen: From Virology to Clinical ApplicationSEMINARS IN LIVER DISEASE
2021Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma GUT AND LIVER
2021Lenvatinib is independently associated with the reduced risk of progressive disease when compared with sorafenib in patients with advanced hepatocellular carcinomaJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2021The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B JOURNAL OF HEPATOCELLULAR CARCINOMA
2021Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients JOURNAL OF KOREAN MEDICAL SCIENCE
2021Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B CLINICAL AND MOLECULAR HEPATOLOGY
2021Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis BHEPATOLOGY RESEARCH
2021Artificial intelligence in liver diseaseJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2021A Case of Lymphocyte-Rich Hepatocellular Carcinoma in a Patient Who Was Treated for Colon Cancer Journal of Liver Cancer(대한간암학회지)
2021Association Between Curative Treatment after Transarterial Radioembolization and Better Survival Outcomes in Patients with Hepatocellular CarcinomaCANCER INVESTIGATION
2021Negligible HCC risk during stringently defined untreated immune-tolerant phase of chronic hepatitis BEUROPEAN JOURNAL OF INTERNAL MEDICINE
2021Cost-Effectiveness Analysis of Antiviral Therapy for Untreated Minimally Active Chronic Hepatitis B to Prevent Liver Disease Progression CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY
2021Predictors of Complete Response in Patients with Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization CURRENT ONCOLOGY
2021Hepatitis B Core-related Antigen Identify Patients With High Viral Load: Systematic Review and Meta-analysis of Individual Participant DataCLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2021Hepatitis B Virus Cure: Targets and Future Therapies INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2021Efficacy and safety of ledipasvir/sofosbuvir in 5,028 Mongolian patients infected with genotype 1 hepatitis C virus: A multicenter study CLINICAL AND MOLECULAR HEPATOLOGY
2021Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY
2021Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy GUT AND LIVER
2021Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma YONSEI MEDICAL JOURNAL
2021Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovirJOURNAL OF VIRAL HEPATITIS
2021Hepatitis B Core-Related Antigen to Indicate High Viral Load: Systematic Review and Meta-Analysis of 10,397 Individual ParticipantsCLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2021Evolution of liver fibrosis and steatosis markers in patients with type 2 diabetes after metformin treatment for 2 yearsJOURNAL OF DIABETES AND ITS COMPLICATIONS
2020A multi-centre study of trends in hepatitis B virus-related hepatocellular carcinoma risk over time during long-term entecavir therapyJOURNAL OF VIRAL HEPATITIS
2020Efficacy of Lenvervimab, a Recombinant Human Immunoglobulin, in Treatment of Chronic Hepatitis B Virus InfectionCLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2020Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion JOURNAL OF HEPATOCELLULAR CARCINOMA
2020Combined use of rosuvastatin and ezetimibe improves hepatic steatosis in patients with dyslipidemiaEUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
2020Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre studyGUT
2020Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study KOREAN JOURNAL OF INTERNAL MEDICINE
2020The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1 in Hepatocellular Carcinoma Treated with Transarterial Radioembolization GUT AND LIVER
2020Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals CANCERS
2020Association between liver fibrosis and appendicular skeletal muscle mass during antiviral therapy in chronic hepatitis BDIGESTIVE AND LIVER DISEASE
2020High body mass index hinders fibrosis improvement in patients receiving long-term tenofovir therapy in hepatitis B virus-related cirrhosisJOURNAL OF VIRAL HEPATITIS
2020Advanced Liver Fibrosis Predicts Unfavorable Long-Term Prognosis in First-Ever Ischemic Stroke or Transient Ischemic AttackCEREBROVASCULAR DISEASES
2020Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study) HEPATOLOGY INTERNATIONAL
2020Factors associated with improvement in MELD score after antiviral treatment in patients with chronic hepatitis BJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2020Sarcopenia Is Independently Associated with the Degree of Liver Fibrosis in Patients with Type 2 Diabetes Mellitus GUT AND LIVER
2020Entecavir and tenofovir on renal function in patients with hepatitis B virus-related hepatocellular carcinomaJOURNAL OF VIRAL HEPATITIS
2020Prognosis of Early-Stage Hepatocellular Carcinoma: Comparison between Trans-Arterial Chemoembolization and Radiofrequency Ablation CANCERS
2020Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement LANCET GASTROENTEROLOGY & HEPATOLOGY
2020Besifovir Dipivoxil Maleate 144-Week Treatment of Chronic Hepatitis B: An Open-Label Extensional Study of a Phase 3 Trial AMERICAN JOURNAL OF GASTROENTEROLOGY
2020A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statementJOURNAL OF HEPATOLOGY
2020RNA Interference Therapy With ARC-520 Results in Prolonged Hepatitis B Surface Antigen Response in Patients With Chronic Hepatitis B Infection HEPATOLOGY
2020IFNL3-adjuvanted HCV DNA vaccine reduces regulatory T cell frequency and increases virus-specific T cell responsesJOURNAL OF HEPATOLOGY

Browse

Links